This topic contains a solution. Click here to go to the answer

Author Question: When the experimenter informs the participant that his or her name will never be attached to his ... (Read 18 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
When the experimenter informs the participant that his or her name will never be attached to his responses during the study, the researcher is promising _____ to the participant.
 
  a. freedom to withdraw c. confidentiality
  b. honesty d. all of these

Question 2

Which of the following is not usually found on informed consent forms?
 
  a. the signature of the participant c. a description of the tasks involved
  b. a statement of confidentiality d. the signature of the researcher



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

scottmt

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

C
Confidentiality assurances include the promise that the participant's responses will not be identified with his or her name.

Answer to Question 2

D
Informed consent forms must include all features that might affect the participant's willingness to participate. Usually the participant signs the form but the researcher does not.




leilurhhh

  • Member
  • Posts: 560
Reply 2 on: Jun 19, 2018
Gracias!


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library